Search Within

Barbara Spitzer

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Center for Hematologic Malignancies (7)
  2. GSK Faculty (7)
  3. Hematologic Malignancies Research (7)
  4. Molecular Pharmacology and Chemistry Program Faculty (7)
  5. Pediatrics, Department of (7)
  6. Sloan Kettering Institute Faculty (7)

More Groups

People
  1. Andrei Krivtsov (3)
  2. Elisa De Stanchina (3)
  3. Farid Boulad (3)
  4. Isabelle Riviere (3)
  5. Kevin Curran (3)
  6. Maria Cancio (3)

More People

Years
  1. 2019 (2)
  2. 2018 (1)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (2)
Publications
  1. Blood (2)
  2. Nature Medicine (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Cancer Discovery (1)
  5. Frontiers in Oncology (1)
Publishers
  1. American Society of Hematology (2)
  2. Nature Publishing Group (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Inc. (1)
  5. Frontiers Media S.A. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
    Journal Article

    Brown, F. C.; Still, E.; Koche, R. P.; Yim, C. Y.; Takao, S.; Cifani, P.; Reed, C.; Gunasekera, S.; Ficarro, S. B.; Romanienko, P.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Loss of BAP1 function leads to EZH2-dependent transformation
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2015)

    Fulltext@MSK | Save
  • Therapeutic re-activation of protein phosphatase 2A in acute myeloid leukemia
    Journal Article

    Ramaswamy, K.; Spitzer, B.; Kentsis, A.
    Frontiers in Oncology (2015)

    Fulltext@MSK | Save